Cargando…
The opposite impact of Janus kinase inhibitor Ruxolitinib on the function of bone marrow mesenchymal stem cells and immune cells in acute GVHD recipients
Autor principal: | |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Lippincott Williams & Wilkins
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10629734/ https://www.ncbi.nlm.nih.gov/pubmed/37941918 http://dx.doi.org/10.1097/BS9.0000000000000171 |
_version_ | 1785132019158614016 |
---|---|
author | Zeng, Defu |
author_facet | Zeng, Defu |
author_sort | Zeng, Defu |
collection | PubMed |
description | |
format | Online Article Text |
id | pubmed-10629734 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | Lippincott Williams & Wilkins |
record_format | MEDLINE/PubMed |
spelling | pubmed-106297342023-11-08 The opposite impact of Janus kinase inhibitor Ruxolitinib on the function of bone marrow mesenchymal stem cells and immune cells in acute GVHD recipients Zeng, Defu Blood Sci Commentary Lippincott Williams & Wilkins 2023-09-08 /pmc/articles/PMC10629734/ /pubmed/37941918 http://dx.doi.org/10.1097/BS9.0000000000000171 Text en Copyright © 2023 The Authors. Published by Wolters Kluwer Health Inc., on behalf of the Chinese Medical Association (CMA) and Institute of Hematology, Chinese Academy of Medical Sciences & Peking Union Medical College (IHCAMS). https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution-Non Commercial-No Derivatives License 4.0 (CCBY-NC-ND) (https://creativecommons.org/licenses/by-nc-nd/4.0/) , where it is permissible to download and share the work provided it is properly cited. The work cannot be changed in any way or used commercially without permission from the journal. |
spellingShingle | Commentary Zeng, Defu The opposite impact of Janus kinase inhibitor Ruxolitinib on the function of bone marrow mesenchymal stem cells and immune cells in acute GVHD recipients |
title | The opposite impact of Janus kinase inhibitor Ruxolitinib on the function of bone marrow mesenchymal stem cells and immune cells in acute GVHD recipients |
title_full | The opposite impact of Janus kinase inhibitor Ruxolitinib on the function of bone marrow mesenchymal stem cells and immune cells in acute GVHD recipients |
title_fullStr | The opposite impact of Janus kinase inhibitor Ruxolitinib on the function of bone marrow mesenchymal stem cells and immune cells in acute GVHD recipients |
title_full_unstemmed | The opposite impact of Janus kinase inhibitor Ruxolitinib on the function of bone marrow mesenchymal stem cells and immune cells in acute GVHD recipients |
title_short | The opposite impact of Janus kinase inhibitor Ruxolitinib on the function of bone marrow mesenchymal stem cells and immune cells in acute GVHD recipients |
title_sort | opposite impact of janus kinase inhibitor ruxolitinib on the function of bone marrow mesenchymal stem cells and immune cells in acute gvhd recipients |
topic | Commentary |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10629734/ https://www.ncbi.nlm.nih.gov/pubmed/37941918 http://dx.doi.org/10.1097/BS9.0000000000000171 |
work_keys_str_mv | AT zengdefu theoppositeimpactofjanuskinaseinhibitorruxolitinibonthefunctionofbonemarrowmesenchymalstemcellsandimmunecellsinacutegvhdrecipients AT zengdefu oppositeimpactofjanuskinaseinhibitorruxolitinibonthefunctionofbonemarrowmesenchymalstemcellsandimmunecellsinacutegvhdrecipients |